A TLR2 agonist is a more effective adjuvant for a Chlamydia major outer membrane protein vaccine than ligands to other TLR and NOD receptors (Q35166960)
Jump to navigation
Jump to search
scientific article published on July 8, 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A TLR2 agonist is a more effective adjuvant for a Chlamydia major outer membrane protein vaccine than ligands to other TLR and NOD receptors |
scientific article published on July 8, 2011 |
Statements
1 reference
A TLR2 agonist is a more effective adjuvant for a Chlamydia major outer membrane protein vaccine than ligands to other TLR and NOD receptors (English)
1 reference
Chunmei Cheng
1 reference
Pooja Jain
1 reference
Ilham Bettahi
1 reference
Sukumar Pal
1 reference
Delia Tifrea
1 reference
Luis M. de la Maza
8 July 2011
1 reference
1 reference
1 reference
29
1 reference
38
1 reference
6641-6649
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference